Repository logo
 

Medical cannabis in schools: The experiences of caregivers

dc.contributor.authorMansell, Holly
dc.contributor.authorZaslawski, Zina
dc.contributor.authorMbabaali, Sophia
dc.contributor.authorKing, Patricia M.
dc.contributor.authorKelly, Lauren E.
dc.contributor.authorLougheed, Taylor
dc.contributor.authorAnderson, Jennifer
dc.contributor.authorHuntsman, Richard J.
dc.contributor.authorAlcorn, Jane
dc.date.accessioned2024-11-25T06:43:47Z
dc.date.available2024-11-25T06:43:47Z
dc.date.issued2023-05
dc.description© The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Paediatric Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
dc.description.abstractAbstract Objectives Implementing medical cannabis (MC) into a child’s daily routine can be challenging and there is a lack of guidance for its therapeutic use in schools in Canada. Our objective was to learn about the experiences of caregivers of school-aged children who require MC. Methods Qualitative description was used and caregivers were interviewed about MC in schools and in general. The transcripts were entered into Dedoose software for qualitative analysis and content analysis was performed. Sentences and statements were ascribed line by line into meaning units and labelled with codes, and organized according to categories and subcategories. Results Twelve caregivers of school-aged children who take MC participated. The most common reasons for treatment were drug-resistant epilepsy (DRE), autism, or other developmental disorders. Approximately half of the participants’ children (n = 6) took MC during the school day and most (5/6) perceived their experiences to be positive or neutral but reported a lack of knowledge about MC. While data saturation was not reached regarding MC in schools, rich dialogues were garnered about MC in general and three categories were identified: challenges (subcategories stigma, finding an authorizer, cost, dosing, and supply); parents as advocates (subcategories required knowledge, attitudes, skills, and sources of information); and caregiver relief for positive outcomes. Conclusions Caregivers demonstrate remarkable tenacity despite the many challenges associated with MC use. Education and practice change are needed to ensure that children using MC can benefit from or continue to experience its positive outcomes within the school environment and beyond.
dc.description.sponsorshipCollege of Pharmacy and Nutrition, University of Saskatchewan and the Canadian Collaborative for Childhood Cannabinoid Therapeutics (C4T)
dc.description.versionPeer Reviewed
dc.identifier.citationHolly Mansell, Zina Zaslawski, Sophia Mbabaali, Patricia M King, Lauren E Kelly, Taylor Lougheed, Jennifer Anderson, Richard J Huntsman, Jane Alcorn, Medical cannabis in schools: The experiences of caregivers, Paediatrics & Child Health, Volume 28, Issue 2, May 2023, Pages 102–106, https://doi.org/10.1093/pch/pxac099
dc.identifier.doi10.1093/pch/pxac099
dc.identifier.urihttps://hdl.handle.net/10388/16279
dc.language.isoen
dc.publisherOxford University Press
dc.rightsAttribution-NonCommercial 2.5 Canadaen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/ca/
dc.subjectCaregiver
dc.subjectEducation
dc.subjectMedical cannabis
dc.subjectSchool
dc.titleMedical cannabis in schools: The experiences of caregivers
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pxac099.pdf
Size:
210.35 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.36 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections